Join
Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo
Zenas BioPharma Inc. logo

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

ByQuantisnow·Wall Street's wire, on your screen.
RPRX· Royalty Pharma plcZBIO· Zenas BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc), ZBIO (Zenas BioPharma Inc.) and more on Quantisnow.